Skip to main content

Treatment for late-stage prostate cancer patients: getting closer to a solution

Images

Contact

Image
Section Head of Communication & Outreach
Tel.+34 93 40 37255

The European Research Council (ERC) has written an ERC Story about Xavier Salvatella, ICREA researcher and leader of the Laboratory of Mollecular Biophysics.

Treatment for late -stage prostate cancer patients: getting closer to a solution

Professor Salvatella is an ERC grantee, whose research is focused in looking for new prostatic cancer therapies that would bypass the resistance that some pacients develop over time. In particular, he studies the folding of the protein androgen receptor as a model for studying the disease.

Xavier Salvatella also starred in a video of IRB Barcelona's series Meet Our Scientists, which has the aim to promote IRB Barcelona scientists, attract talent, and disseminate biomedicine.

 

 

 

 

 

 

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).